Recently, the Nipah virus has broken out in India. With a high case fatality rate of 40%–75%, significant neuroinvasiveness and no approved specific therapeutics to date, it has once again drawn great attention from the global public health community and scientific research circles.

AntibodySystem focuses on Nipah virus research and provides a full range of related Kits, Recombinant Proteins and Antibodies, offering comprehensive support for all types of Nipah virus research. These high-quality and reliable products have been widely cited in recent years by world-leading research institutions, including the Institute of Virology at the University of Marburg (Germany), Fred Hutchinson Cancer Center (USA), the University of Tokyo (Japan), the Institute of Virology of the Chinese Academy of Sciences and Zhongshan School of Medicine of Sun Yat-sen University (China). Relevant research findings have been successively published in prestigious journals such as Emerg Microbes Infect. and JCI Insight. Our products cover classic experimental techniques including neutralization assay, WB, IF and ELISA, and their efficacy has been fully validated by solid experimental data from both in vitro cellular experiments and in vivo animal studies.